Intratumoral heterogeneity on dedicated breast positron emission tomography predicts malignancy grade of breast cancer

被引:0
作者
Norio Masumoto
Takayuki Kadoya
Shinsuke Sasada
Akiko Emi
Koji Arihiro
Morihito Okada
机构
[1] Hiroshima University,Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine
[2] Hiroshima University Hospital,Department of Anatomical Pathology
来源
Breast Cancer Research and Treatment | 2018年 / 171卷
关键词
Breast cancer; Dedicated breast PET; FDG; Intratumoral heterogeneity; Clinicopathological factors;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:315 / 323
页数:8
相关论文
共 185 条
[1]  
Vansteenkiste JF(1999)Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucosepositron emission tomography scan in non-small-cell lung cancer: an analysis of 125 cases. Leuven Lung Cancer Group J Clin Oncol 17 3201-3206
[2]  
Stroobants SG(1992)Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment J Nucl Med 33 333-339
[3]  
Dupont PJ(2008)Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures J Clin Oncol 26 4746-4751
[4]  
De Leyn PR(2012)Prognostic impact of (18)FDG-PET-CT findings in clinical stage III and IIB breast cancer J Natl Cancer Inst 104 1879-1887
[5]  
Verbeken EK(1992)Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity J Nucl Med 33 325-329
[6]  
Deneffe GJ(2014)Early assessment with 18F-fluorodeoxyglucose positron emission tomography/computed tomography can help predict the outcome of neoadjuvant chemotherapy in triple negative breast cancer Eur J Cancer 50 1864-1871
[7]  
Okazumi S(2007)[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy Eur J Nucl Med Mol Imaging 34 1915-1924
[8]  
Isono K(2012)Changes in 18F-FDG tumor metabolism after a first course of neoadjuvant chemotherapy in breast cancer: influence of tumor subtypes Ann Oncol 23 2572-2577
[9]  
Enomoto K(2002)FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters Eur J Nucl Med Mol Imaging 29 1317-1323
[10]  
Kikuchi T(2006)Tumor 18F-FDG incorporation is enhanced by attenuation of P53 function in breast cancer cells in vitro J Nucl Med 47 1525-1530